annual cash & cash equivalents:
$156.32M+$23.00M(+17.26%)Summary
- As of today (July 26, 2025), ABCL annual cash & cash equivalents is $156.32 million, with the most recent change of +$23.00 million (+17.26%) on December 31, 2024.
- During the last 3 years, ABCL annual cash & cash equivalents has fallen by -$319.82 million (-67.17%).
- ABCL annual cash & cash equivalents is now -73.69% below its all-time high of $594.12 million, reached on December 31, 2020.
Performance
ABCL Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$159.27M+$2.94M(+1.88%)Summary
- As of today (July 26, 2025), ABCL quarterly cash & cash equivalents is $159.27 million, with the most recent change of +$2.94 million (+1.88%) on March 31, 2025.
- Over the past year, ABCL quarterly cash & cash equivalents has increased by +$35.69 million (+28.89%).
- ABCL quarterly cash & cash equivalents is now -79.91% below its all-time high of $792.57 million, reached on June 30, 2021.
Performance
ABCL quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ABCL Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.3% | +28.9% |
| 3 y3 years | -67.2% | -70.8% |
| 5 y5 years | +1969.7% | - |
ABCL Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.2% | +17.3% | -79.9% | +28.9% |
| 5 y | 5-year | -73.7% | +1969.7% | -79.9% | +74.9% |
| alltime | all time | -73.7% | +1969.7% | -79.9% | +2008.7% |
ABCL Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $159.27M(+1.9%) |
| Dec 2024 | $156.32M(+17.3%) | $156.32M(+23.4%) |
| Sep 2024 | - | $126.64M(-14.6%) |
| Jun 2024 | - | $148.31M(+20.0%) |
| Mar 2024 | - | $123.57M(-7.3%) |
| Dec 2023 | $133.32M(-65.5%) | $133.32M(-22.7%) |
| Sep 2023 | - | $172.42M(-4.1%) |
| Jun 2023 | - | $179.75M(-6.9%) |
| Mar 2023 | - | $193.02M(-50.1%) |
| Dec 2022 | $386.54M | $386.54M(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $371.97M(-53.0%) |
| Jun 2022 | - | $790.62M(+44.9%) |
| Mar 2022 | - | $545.72M(+14.6%) |
| Dec 2021 | $476.14M(-19.9%) | $476.14M(-8.0%) |
| Sep 2021 | - | $517.69M(-34.7%) |
| Jun 2021 | - | $792.57M(+15.6%) |
| Mar 2021 | - | $685.79M(+15.4%) |
| Dec 2020 | $594.12M(+7766.0%) | $594.12M(+552.3%) |
| Sep 2020 | - | $91.08M(+1105.9%) |
| Dec 2019 | $7.55M(-27.7%) | $7.55M |
| Dec 2018 | $10.44M | - |
FAQ
- What is AbCellera Biologics Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual cash & cash equivalents year-on-year change?
- What is AbCellera Biologics Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly cash & cash equivalents year-on-year change?
What is AbCellera Biologics Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of ABCL is $156.32M
What is the all time high annual cash & cash equivalents for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual cash & cash equivalents is $594.12M
What is AbCellera Biologics Inc. annual cash & cash equivalents year-on-year change?
Over the past year, ABCL annual cash & cash equivalents has changed by +$23.00M (+17.26%)
What is AbCellera Biologics Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ABCL is $159.27M
What is the all time high quarterly cash & cash equivalents for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly cash & cash equivalents is $792.57M
What is AbCellera Biologics Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, ABCL quarterly cash & cash equivalents has changed by +$35.69M (+28.89%)